Zhangjiagang Freetrade Science & Technology Group Co Ltd

The company's capital structure is characterized by a low debt-to-equity ratio of 0.08, indicating a conservative leverage position. However, the free cash flow is negative at -135.94 million CNY, suggesting that the company is currently investing more in capital expenditures than it is generating in operating cash flow. The price-to-book ratio of 1.59 implies that the market value is trading at a premium to the book value of the company's equity.

Profitability metrics show a challenging performance, with a return on equity of -3.71% and a return on assets of -3.03%, both significantly below the industry median for commodity chemicals. The company reported a net loss of 91.81 million CNY, and an operating loss of 49.93 million CNY, indicating a lack of operational profitability. Gross profit of 208.06 million CNY is insufficient to cover operating expenses, contributing to the negative operating income.

Geographically and segment-wise, the company's exposure is not disclosed in the available data, but the current financials suggest a concentration of risk in a single business line or region. The absence of segmental or geographic breakdown limits the ability to assess diversification.

Looking ahead, the company is expected to face continued challenges, with no clear indication of revenue growth in the current or next fiscal year. The negative operating cash flow and free cash flow suggest that the company may need to rely on external financing to fund operations and capital expenditures. The current liquidity position is rated as medium, with a current ratio of 5.18, indicating that the company has sufficient short-term assets to cover its liabilities.

Risk factors include the company's negative net cash position after subtracting total debt, which could limit its financial flexibility. The dilution risk is currently rated as low, but the negative free cash flow and potential need for external financing could increase this risk in the future. Analysts have provided a mean price target of 5.13 CNY, with a median and high target also at 5.13 CNY, suggesting a consensus view of moderate upside potential.

Recent events and filings have not been disclosed in the available data, but the company's financial performance and risk profile suggest that it is navigating a difficult operating environment. The lack of profitability and the need for capital expenditures indicate that the company is in a growth or restructuring phase.